eft ventricular (LV) dilatation and systolic dysfunction are the hallmarks of idiopathic dilated cardiomyopathy (DCM). 1 Although the degree of LV dilatation is generally thought to be one of the predictors of poor outcome, 2-5 several investigators have reported that the prognosis of patients with mild LV dilatation (MDCM) is variable. [6] [7] [8] However, the long-term prognosis and changes in the echocardiographic parameters of such patients are unknown and so we aimed to elucidate the long-term prognosis and predictive factors in patients with MDCM.
Cardiac Catheterization and Angiography
Right-and left-heart cardiac catheterization was performed with fluid-filled catheters and the mean right atrial pressure, RV end-diastolic pressure, mean pulmonary artery pressure, pulmonary wedge pressure, and LV end-diastolic pressure were recorded. Cardiac output was measured by the thermodilution method. Biplane left ventriculography was performed in the 30-degree right anterior oblique and 60-degree left anterior oblique projections. Selective coronary angiography was performed using the Judkins technique.
Echocardiography
Echocardiographic studies were performed with a 3.5 MHz transducer (Toshiba 65A or SSH 160A, Toshiba Co, Nasu, Japan). The LV dimensions, LV fractional shortening and left atrial dimensions were measured at baseline and during the follow-up period. Cardiac dimensions were assessed from the M-mode echocardiograms according to the criteria of the American Society of Echocardiography. 10 
Follow-up
Follow-up started from the time of cardiac catheterization and was accomplished using available medical records and telephone interviews with the patients and/or referring physicians. Follow-up echocardiographic studies were performed at outpatient clinics when the patients were in a stable condition. The specified endpoints were heart failure death, sudden death, and re-hospitalization for worsening heart failure.
Statistical Analysis
Data are presented as the mean ± SD. Statistical analysis was carried out using Statview V5.0 (SAS Institute, Cary, NC, USA). The paired t-test was used to compare changes in the same group. The unpaired t-test and chi squared tests were used to compare 2 groups. A Cox proportional hazards regression model was used to identify independent factors predicting cardiac events. A p value less than 0.05 was considered statistically significant.
Results

Clinical Characteristics and Cardiac Events (Table 1)
During the follow-up period of 6.8±3.7 years, there were 9 cardiac events (5 heart failure deaths, 2 sudden deaths, and 2 re-hospitalizations for heart failure). The dimensions and systolic function of the left ventricle were similar and there were no other differences in baseline characteristics between the 2 groups. Medical treatment did not differ significantly between the patients with and those without cardiac events, except for the use of -blockers and digitalis: 5 of the 12 patients (42%) without cardiac events received -blockers compared with none of the patients with cardiac events.
Changes in the Echocardiographic Parameters (Table 2)
Of the 21 patients, follow-up echocardiographic data were available for 17 patients. The mean time to follow-up echocardiography was 5.5±3.4 years. A significant decrease in the LV end-diastolic dimension and improvement in the fractional shortening were observed in patients without cardiac events. In contrast, there was no change in patients with cardiac events. Moreover, although the left atrial dimensions decreased slightly in patients without cardiac events, increased left atrial dimensions were observed at follow-up in patients with cardiac events. (Table 3) Based on a univariate proportional hazard model, LV end-diastolic pressure and mean pulmonary artery pressure at diagnosis, and the LV and left atrial dimensions at follow-up were significant predictors of poor outcome. Based on multivariate analysis, the left atrial dimensions were the only follow-up echocardiographic finding that was a significant predictor of poor outcome. 
Proportional Hazard Analysis
Discussion
We have shown that the long-term prognosis of patients with MDCM is relatively poor, especially in patients with abnormal hemodynamic findings and progressive left atrial dilation.
Previous Studies of Ventricular Dilatation and Prognosis in Patients With DCM
In earlier reports, the natural history of patients with DCM was for a poor prognosis, with a mortality rate of 50% at 5 years 4,11 and despite advances in medical therapy, including angiotensin-converting enzyme inhibitors (ACEI) and -blockers, the prognosis is still relatively poor, with a 5-year mortality of 20%. 2, 12, 13 The degree of LV end-diastolic dilatation is considered to be one of the primary prognostic predictors, 2-5 but Keren et al reported in 1985 that a subgroup of patients with DCM presented in end-stage heart failure despite mild LV dilatation. 6 Gavazzi et al studied 144 patients with DCM to determine the variability and prognostic importance of LV dilatation and reported that mild dilatation was not uncommon (31% of patients with DCM). 8 These patients are a heterogeneous group that includes some in the early stages of the disease and others with severe LV dysfunction and minimal dilatation. However, those earlier reports have several limitations, such as the relatively short follow-up period (from 20 to 30 months) and the infrequent use of ACEI and -blockers.
Ventricular Dilatation and Prognosis in the Present Study
The prevalence of MDCM was 15% in our patient cohort, which is less than that reported by Gavazzi et al 8 possibly because of differences in patient selection, criteria and the definition of MDCM. During the follow-up period, there were 9 cardiac events in the 21 patients with MDCM, and patients with impaired hemodynamics had an especially poor prognosis.
Changes in the Echocardiographic Findings of Patients With MDCM
In a report with a follow-up period of 30 months, 19% of patients with MDCM had an increase in the size of the left ventricle and 16% had a decrease, 8 but the changes in LV size and systolic function over a longer period have not been determined. In the present study, patients with cardiac events showed no change in LV size or systolic function, but did develop dilation of the left atrium during the follow-up period of approximately 7 years. In contrast, during that same time period patients without cardiac events showed a decrease in LV size and improvement in systolic function. Although the precise mechanisms of these results are unclear, there are several possibilities. First, spontaneous improvement in systolic function can occur in patients with DCM. 14-17 Steimle et al reported that 27% of patients with recent onset DCM showed improvement in systolic function, 16 and they also noticed that the LV dimensions of patients who showed improvement were less than those of patients who did not. Therefore, there is a subset of patients with MDCM who will experience spontaneous improvement in systolic function, although, in our study, patients with alcohol-induced myocardial damage or acute myocarditis were carefully excluded. Second, none of the patients with cardiac events received -blockers compared with 42% of the patients without cardiac events. However, it is also important to note that there was no significant difference in the initial hemodynamic findings between those who did and those who did not receive -blockers. Although, to our knowledge, it has not been reported whether -blockers should be given to patients with MDCM, it is well established that -blockers can potentially reverse the remodeling of the left ventricle in patients with DCM or ischemic cardiomyopathy. 18, 19 It is therefore possible that this treatment may have contributed to the decrease in LV size and improvement in systolic function observed in some patients without cardiac events. Finally, left atrial dimensions and function have been found to correlate with exercise capacity and prognosis in patients with DCM. [20] [21] [22] Modena et al reported that a dilated left atrium (≥45 mm) was an independent predictor of prognosis in 123 patients with DCM. 22 In our present study, there was no difference in the prevalence of atrial fibrillation and the severity of mitral regurgitation between the 2 groups and so left atrial dilation may have resulted from overall hemodynamic deterioration in the patients with cardiac events, although the precise mechanism remains undetermined.
In conclusion, patients with MDCM represent a common subgroup of DCM and the condition has 2 important features: one group of patients with early and mild DCM may stabilize or improve through the natural course or with appropriate medications; the other group shows definite impairment of hemodynamics together with left atrial dilation, despite modest LV dilation and it is this group which has the poorer prognosis and must be carefully followed.
Study Limitations
First, the study was retrospective with a small number of patients. Second, none of the patients with cardiac events were given -blockers, because of the retrospective study design. Third, we did not quantify LV diastolic function. Finally, myocardial biopsies were not performed. Despite these limitations, we believe that the results from long follow-up period give an indication of the true prognosis of patients with MDCM.
